6 lines simultaneous manufacturing 42 tons of liquid medicine..."The largest single factory"
"Preparing for the fall seasonal flu, full operation of the factory"
Daewon Pharmaceutical is operating its Jincheon plant at full capacity in preparation for the flu season in the fall.
The company plans to ensure that there is no shortage of seasonal flu medicines.
The Jincheon plant was completed in 2019 by Daewon Pharmaceutical with an investment of more than 80 billion won and occupies a total area of about 18,000 square meters (approximately 5,500 pyeong).
It is the largest single plant for oral liquid medication in Korea.
The Jincheon plant is composed of 6 lines, which can simultaneously manufacture 42 tons of oral liquid medication.
When converted to stick-type pouches, this amounts to 2.856 million pouches per day and 560 million pouches per year.
The plant was designed to be fully automated from the outset, eliminating any contamination of the drug by outside air, from the input of raw materials, through the manufacturing of oral liquids, to the subdivision into disposable pouches.
After manufacturing, the robots automatically transport the boxes to the 42-meter high warehouse and at the time of shipping, the robots automatically recognize the location of products, eliminating the need for human hands.
Daewon Pharmaceutical has recently been operating all of its facilities at full capacity on a two-shift basis to prepare for the onset of respiratory diseases during the season.
A representative from the company said, "We are paying more attention to the production of Codaewon S Syrup, which has an additional indication for infections, and Coldaewon Kids Pen Syrup, which recently resumed production after improving its formulation. We are making sure that there is no supply shortage of cold medicines and expectorants."
[WIKI KOREA=Cho Pil Hyun, Staff Reporter]